Quality of Life in Schizophrenic Patients
Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00597168
Collaborator
(none)
124
46
24
2.7
0.1
Study Details
Study Description
Brief Summary
This is a non-interventional study evaluating quality of life in schizophrenic patients treated with atypical antipsychotics, in the ambulatory setting. This is a 9-month, observational, multicentric prospective study.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
124 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
QUALITY: A Non-interventional Study Evaluating Quality Of Life in Schizophrenic Patients Treated With Atypical Antipsychotics, in the Ambulatory Setting. A 9-month, Observational, Multicentric Prospective Study.
Study Start Date
:
Oct 1, 2007
Actual Primary Completion Date
:
Oct 1, 2009
Actual Study Completion Date
:
Oct 1, 2009
Outcome Measures
Primary Outcome Measures
- Change from baseline of QOL assessed by the SWN-K after 9 months of treatment with AAPs. [9 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients diagnosed with Schizophrenia treated with atypical antipsychotics (ambulatory patients).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Research Site | Aalst | Belgium | ||
2 | Research Site | Asse | Belgium | ||
3 | Research Site | Bertrix | Belgium | ||
4 | Research Site | Bierbeek | Belgium | ||
5 | Research Site | Boechout | Belgium | ||
6 | Research Site | Bon-secours | Belgium | ||
7 | Research Site | Bruxelles | Belgium | ||
8 | Research Site | Dendermonde | Belgium | ||
9 | Research Site | Diest | Belgium | ||
10 | Research Site | Duffel | Belgium | ||
11 | Research Site | Eeklo | Belgium | ||
12 | Research Site | Elsene | Belgium | ||
13 | Research Site | Embourg | Belgium | ||
14 | Research Site | Floreffe | Belgium | ||
15 | Research Site | Gent | Belgium | ||
16 | Research Site | Halle | Belgium | ||
17 | Research Site | Henri-Chapelle | Belgium | ||
18 | Research Site | Herstal | Belgium | ||
19 | Research Site | Jambes | Belgium | ||
20 | Research Site | Kortenberg | Belgium | ||
21 | Research Site | Kortrijk | Belgium | ||
22 | Research Site | La Louviere | Belgium | ||
23 | Research Site | Leut | Belgium | ||
24 | Research Site | Leuven | Belgium | ||
25 | Research Site | Libramont | Belgium | ||
26 | Research Site | Liege | Belgium | ||
27 | Research Site | Lierneux | Belgium | ||
28 | Research Site | Melle | Belgium | ||
29 | Research Site | Menen | Belgium | ||
30 | Research Site | Mol | Belgium | ||
31 | Research Site | Mons | Belgium | ||
32 | Research Site | Oostende | Belgium | ||
33 | Research Site | Ottignies | Belgium | ||
34 | Research Site | Roeselare | Belgium | ||
35 | Research Site | Schaerbeek | Belgium | ||
36 | Research Site | Sint-Kruis (Brugge) | Belgium | ||
37 | Research Site | Sint-Lambrechts-Woluwe | Belgium | ||
38 | Research Site | Sint-Michiels | Belgium | ||
39 | Research Site | Sint-Niklaas | Belgium | ||
40 | Research Site | Sint-Truiden | Belgium | ||
41 | Research Site | Sleidinge | Belgium | ||
42 | Research Site | Tielt | Belgium | ||
43 | Research Site | Tienen | Belgium | ||
44 | Research Site | Veurne | Belgium | ||
45 | Research Site | Waregem | Belgium | ||
46 | Research Site | Woluwe-Saint-Lambert | Belgium |
Sponsors and Collaborators
- AstraZeneca
Investigators
- Principal Investigator: Prof Vermylen, UZ Leuven
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00597168
Other Study ID Numbers:
- NIS-NBE-SER-2006/1
First Posted:
Jan 17, 2008
Last Update Posted:
Jun 9, 2010
Last Verified:
Jun 1, 2010
Keywords provided by ,
,
Additional relevant MeSH terms: